KEY CHANGES TO THE 2010 WADA PROHIBITED LIST
Please find attached a summary of significant changes for your convenience. Please pay particular attention to the following key changes:
§ The status of salbutamol and salmeterol (used for the treatment of asthma). Therapeutic use of inhaled salbutamol (maximum 1600 micrograms per day) and salmeterol will not be prohibited as of 1 January 2010 with a declaration of use.
§ Supplemental oxygen (hyperoxia) will no longer be prohibited.
§ The status of platelet-derived preparations (such as Platelet Rich Plasma (PRP), ‘blood spinning') has been clarified by WADA. It will be prohibited when administered by intramuscular route, but other routes of administration will require a declaration of use.
§ Pseudoephedrine will be reintroduced to the Prohibited List and will be prohibited above 150 micrograms per millilitre.
These changes are effective from 1 January 2010